東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Synthesis and vaccine evaluation of ...

Chuang, Hong-Yang.

FindBook

Google Book

Amazon

博客來

Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer/ by Hong-Yang Chuang.
作者:	Chuang, Hong-Yang.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2015.,
面頁冊數:	xiii, 108 p. :ill., digital ;24 cm.
內容註:	Chemical Synthesis of Proposed RM2 and Derivatives -- RM2 Antigen: Structural Characterization and Determination of KD,surf for Multivalent Carbohydrate-Protein Interaction -- RM2 Antigen: Synthesis of Glycoconjugates -- Synthesis of the Heptasaccharide RM2 Prostate Tumor Antigen: Chemical Synthesis of Heptasaccharide and Tetrasaccharide (Inner Core of the RM2 Antigen)
Contained By:	Springer eBooks
標題:	Cancer vaccines. -
電子資源:	http://dx.doi.org/10.1007/978-3-662-46848-7
ISBN:	9783662468487 (electronic bk.)

Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer
Chuang, Hong-Yang.

Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer[electronic resource] /by Hong-Yang Chuang. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - xiii, 108 p. :ill., digital ;24 cm. - Springer theses,2190-5053. - Springer theses..

Chemical Synthesis of Proposed RM2 and Derivatives -- RM2 Antigen: Structural Characterization and Determination of KD,surf for Multivalent Carbohydrate-Protein Interaction -- RM2 Antigen: Synthesis of Glycoconjugates -- Synthesis of the Heptasaccharide RM2 Prostate Tumor Antigen: Chemical Synthesis of Heptasaccharide and Tetrasaccharide (Inner Core of the RM2 Antigen)

This thesis focuses on the synthesis and vaccine evaluation of the prostate tumor- associated carbohydrate antigen RM2. The author first presents the use of the [1+2+3] one-pot sequential strategy to successfully synthesise the RM2 antigen and its analogues as single stereoisomers in every glycosylation step, producing good yields and stereoselectivity. He then introduces the conjugation of the synthetic RM2 antigen to the carrier protein CRM197 in an average number of 1-10 to create the prostate cancer vaccine candidate, which is combined with α-galactosylceramide C1, its analogue C34, or Alu. The results of the vaccination studies in mice are also described and indicate that the strongest anti-RM2 antigen titer is exhibited when one molecule of diphtheria toxin (DT) is conjugated with an average of 4.7 molecules of RM2 antigen (DT-RM4.7) and adjuvanted with the glycolipid C34. More importantly, the induced mouse antibodies mediate the effective complement-dependent cytotoxicity (CDC) against the prostate cancer cell line LNCap. The study presented in this thesis is the first ever to successfully synthesize this complex glycan molecule. Owing to the steric hindrance of the adjacent sialyl moiety, the introduction of two sialic acid units to the compact and rigid 3,4 dibranched galactoside unit is very challenging and the [Beta]-selective and efficient glycosylation of the galactosamine moiety at the 4-position of dibranched galactose is also problematic.

ISBN: 9783662468487 (electronic bk.)

Standard No.: 10.1007/978-3-662-46848-7doiSubjects--Topical Terms:

840697
Cancer vaccines.

LC Class. No.: RC271.I48

Dewey Class. No.: 616.994061

Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer
LDR:02906nmm m2200325 m 4500 001 2001546
003 DE-He213
005 20151109134634.0
006 m d
007 cr nn 008maaau
008 151215s2015 gw s 0 eng d
020 $a 9783662468487 (electronic bk.)
020 $a 9783662468470 (paper)
024 7 $a 10.1007/978-3-662-46848-7 $2 doi
035 $a 978-3-662-46848-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I48
072 7 $a PSBF $2 bicssc
072 7 $a SCI013040 $2 bisacsh
082 0 4 $a 616.994061 $2 23
090 $a RC271.I48 $b C559 2015
100 1 $a Chuang, Hong-Yang. $3 2145309
245 1 0 $a Synthesis and vaccine evaluation of the tumor associated carbohydrate antigen RM2 from prostate cancer $h [electronic resource] / $c by Hong-Yang Chuang.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a xiii, 108 p. : $b ill., digital ; $c 24 cm.
490 1 $a Springer theses, $x 2190-5053
505 0 $a Chemical Synthesis of Proposed RM2 and Derivatives -- RM2 Antigen: Structural Characterization and Determination of KD,surf for Multivalent Carbohydrate-Protein Interaction -- RM2 Antigen: Synthesis of Glycoconjugates -- Synthesis of the Heptasaccharide RM2 Prostate Tumor Antigen: Chemical Synthesis of Heptasaccharide and Tetrasaccharide (Inner Core of the RM2 Antigen)
520 $a This thesis focuses on the synthesis and vaccine evaluation of the prostate tumor- associated carbohydrate antigen RM2. The author first presents the use of the [1+2+3] one-pot sequential strategy to successfully synthesise the RM2 antigen and its analogues as single stereoisomers in every glycosylation step, producing good yields and stereoselectivity. He then introduces the conjugation of the synthetic RM2 antigen to the carrier protein CRM197 in an average number of 1-10 to create the prostate cancer vaccine candidate, which is combined with α-galactosylceramide C1, its analogue C34, or Alu. The results of the vaccination studies in mice are also described and indicate that the strongest anti-RM2 antigen titer is exhibited when one molecule of diphtheria toxin (DT) is conjugated with an average of 4.7 molecules of RM2 antigen (DT-RM4.7) and adjuvanted with the glycolipid C34. More importantly, the induced mouse antibodies mediate the effective complement-dependent cytotoxicity (CDC) against the prostate cancer cell line LNCap. The study presented in this thesis is the first ever to successfully synthesize this complex glycan molecule. Owing to the steric hindrance of the adjacent sialyl moiety, the introduction of two sialic acid units to the compact and rigid 3,4 dibranched galactoside unit is very challenging and the [Beta]-selective and efficient glycosylation of the galactosamine moiety at the 4-position of dibranched galactose is also problematic.
650 0 $a Cancer vaccines. $3 840697
650 0 $a Glycosides $x Therapeutic use. $3 2145310
650 0 $a Prostate $x Cancer $x Prevention. $3 2058968
650 1 4 $a Chemistry. $3 516420
650 2 4 $a Carbohydrate Chemistry. $3 1006178
650 2 4 $a Vaccine. $3 1001012
650 2 4 $a Immunology. $3 611031
650 2 4 $a Medicinal Chemistry. $3 892420
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Springer theses. $3 1314442
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-46848-7
950 $a Chemistry and Materials Science (Springer-11644)